COMMUNIQUÉS West-GlobeNewswire

Impressive $3.3M investment in Basic Mental Health Research
19/03/2024
Three recipients, along with their dedicated research teams, receive $1.1 million each to advance our understanding of mental health conditions at a fundamental level MONTREAL, March 19, 2024 (GLOBE NEWSWIRE) -- In [...]
Investissement important de 3,3 M$ dans la recherche fondamentale en santé mentale
19/03/2024
Trois lauréats et leurs équipes de recherche attitrées reçoivent chacun 1,1 million de dollars pour faire progresser notre compréhension des problèmes de santé mentale à un niveau fondamental. MONTRÉAL, 19 mars 2024 ( [...]
Disclosure notification from Mawer Investment Management Ltd.
19/03/2024
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 19 March 2024 – 6PM CET Disclosure notification from Mawer Investment Management Ltd. On 18 March 2024, Fagron received a notification pursuant to [...]
Virbac: Public Release of the Year-End Consolidated Accounts at 31 December 2023
19/03/2024
Public release of Virbac Consolidated Accounts at 31 December 2023. The Group released its 2023 Consolidated Accounts. The document is available on the corporate website, at corporate.virbac.com, under “Investors”, “ [...]
Virbac: Communiqué de mise à disposition des comptes consolidés au 31 décembre 2023
19/03/2024
Communiqué de mise à disposition des comptes consolidés au 31 décembre 2023. Le Groupe annonce avoir mis à la disposition du public ses comptes consolidés au 31 décembre 2023 sur le site internet du Groupe, à l’adresse [...]
VIRBAC: 2023 ANNUAL RESULTS
19/03/2024
Revenue up 4.9%, enabling market share gains despite difficulties in 2023 2023 operating profitability 1 at an all-time high of 23.2% of revenue Up 0.4 points compared to 2022 Strong momentum expected in 2024 Expected [...]
Virbac : Résultats annuels 2023
19/03/2024
Chiffre d’affaires en progression de 4,9% permettant des gains de parts de marché malgré des difficultés en 2023 Rentabilité opérationnelle 1 2023 à un niveau historique de 23,2% du chiffre d’affaires En progression de [...]
Zealand Pharma major shareholder announcement: Polar Capital
19/03/2024
Company announcement – No. 16 / 2024 Zealand Pharma major shareholder announcement: Polar Capital Copenhagen, Denmark, 19 March 2024 – Zealand Pharma A/S (“Zealand”) (Nasdaq: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen- [...]
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
19/03/2024
Company announcement – No. 15 / 2024 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark, March [...]
NMDP Receives Record-Breaking $5 Million Philanthropic Gift
19/03/2024
The Moore family’s donation accelerates NMDP’s lifesaving mission MINNEAPOLIS, March 19, 2024 (GLOBE NEWSWIRE) -- NMDP SM , formerly Be The Match, recently received a $5 million gift from the Moore family – the largest [...]
DepYmed Receives Clearance from U.S. Food and Drug Administration to Initiate Phase 1 Clinical Trial for DPM-1003 for the Treatment of Rett Syndrome
19/03/2024
FARMINGDALE, N.Y., March 19, 2024 (GLOBE NEWSWIRE) -- DepYmed, Inc. (“DepYmed” or the “Company”) is a clinical-stage pharmaceutical company focused on developing transformative medicines for many poorly treated diseases [...]
BettorEdge to Offer Responsible Gaming Resources and Connections to Problem Gambling Care through Birches Health Partnership
19/03/2024
NEW YORK, March 19, 2024 (GLOBE NEWSWIRE) -- BettorEdge, a national online sports betting exchange and social platform, has joined forces with Birches Health to provide its audience with new Responsible Gaming education [...]
New Study Reveals 40% of Workplace-Insured Americans Delay Care Due to Cost, Adversely Impacting Workplace Culture and Productivity
19/03/2024
COLUMBIA, Mo., March 19, 2024 (GLOBE NEWSWIRE) -- Paytient , the leading provider of healthcare affordability solutions, released today a study commissioned from independent research group Nonfiction on workplace- [...]
CHARM Therapeutics Announces Foundation of Scientific Advisory Board (SAB)
19/03/2024
PRESS RELEASE CHARM Therapeutics Announces Foundation of Scientific Advisory Board (SAB) LONDON – 19 March 2024 -- CHARM Therapeutics (“CHARM”, “The Company”), a 3D deep-learning research company discovering and [...]
Gynesonics Announces Key Executive Appointments to Further Accelerate and Expand Adoption of the Sonata Treatment
19/03/2024
REDWOOD CITY, Calif., March 19, 2024 (GLOBE NEWSWIRE) -- Gynesonics ® , Inc. a privately-held women’s healthcare medical device company focused on the development of minimally invasive solutions for symptomatic uterine [...]
Merit Medical Launches the Micro ACE™ Advanced Micro-Access System
19/03/2024
Micro ACE combines a unique balance of stiffness and resiliency to achieve successful micro-access in challenging cases SOUTH JORDAN, Utah, March 19, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), [...]
Ibogaine By David Dardashti Begins Design on Algorithm for Quantum Electrodynamics
19/03/2024
Ibogaine By David Dardashti Develops Algorithm for Quantum Electrodynamics to Optimize Treatment Times MIAMI, March 19, 2024 (GLOBE NEWSWIRE) -- Ibogaine By David Dardashti is proud to announce the development of a [...]
Medigene AG to participate in the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
19/03/2024
Planegg/Martinsried, March 19, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid [...]
JenaValve’s Trilogy THV System Highlighted at CRT 2024
19/03/2024
IRVINE, Calif., March 19, 2024 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced highlights from the Cardiovascular [...]

Pages